Ireland
--:--IST
Latest
Clinical Trials in South Korea / NCT06178939
Starting soon Not applicable

Effects of Cognitive Intervention Therapy on Postoperative Delirium

NCT06178939 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2023-12
Last updated
2023-12-21

Condition(s) studied

Spinal StenosisDisc HerniationLung NeoplasmsCarcinoma, Hepatocellular

Investigational drug(s) / intervention(s)

control groupintervention group

control group: The entire process is carried out according to Severance Hospital surgical protocols. The patients of control group will receive education from the research team about the importance of nutrition and exercise before and after surgery.

intervention group: For the intervention group, the entire process is carried out according to the Severance Hospital surgical protocol, and the research team provides education before surgery on the importance of nutrition and exercise before and after surgery. In addition, the cognitive training program developed by Rowan is taught with the goal of performing it for at least 10 hours before the surgery, it is conducted the training program after the surgery.

Study summary

This study is a prospective, single-center, randomized controlled trial to compare whether applying cognitive intervention therapy before and after surgery in elderly patients aged 65 years or older undergoing non-cardiac surgery can reduce the incidence of postoperative delirium compared to conservative treatment.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Elderly patients aged 65 and above. * Patients undergoing orthopedic, thoracic, or hepatopancreatobiliary surgery under general anesthesia with an expected surgery duration of 2 hours or more. * Patients scheduled for arterial catheterization. Exclusion Criteria: * Patients with uncontrolled systemic conditions such as diabetes and hypertension. * Those with visual impairment. * Patients with cognitive impairment based on the MMSE-DS criteria. * Individuals experiencing difficulty in communication. * Those diagnosed with neurological disorders (such as brain hemorrhage, stroke, brain tumor, dementia, Parkinson's disease, cognitive impairment, depression, etc.). * Patients diagnosed with alcohol or substance addiction.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine Seoul South Korea

More Yonsei University trials in South Korea

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06178939 on ClinicalTrials.gov ↗ ← All trials in South Korea